New products added to monopoly generics tag
Posted in News
The newsletters in June and November highlighted the cost of monopoly generics for a defined list of products. Since publication of the November newsletter, two further products have been added to the ‘monopoly generics’ Tag in Define and Refine so that Trusts can continue to monitor their spending in this area. The additional products are alimemazine 10mg tablets and lithium carbonate 250mg tablets.